Supplementary Information: Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry

Somsen,Govert;Haselberg,Rob;Klara Michalikova;Elena Dominguez-Vega;Miroslav Polasek;

Supplementary Information: Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry

Published on: February 28, 2019

Govert W. Somsen, Rob Haselberg, Klara Michalikova, Elena Dominguez-Vega, Miroslav Polasek

LCGC Europe

LCGC Europe, LCGC Europe-03-01-2019, Volume 32, Issue 3

This information is supplementary to the article “Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis-Mass Spectrometry” that was published in the March 2019 issue of LCGC Europe.

This information is supplementary to the article “Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry” that was published in the March 2019 issue of LCGC Europe.